Physician profile
Jennifer Fraley
NPI 1306019195
$2,513.74
in general payments reported to CMS, 2019-2025
32 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $293 · 2021: $259 · 2022: $599 · 2023: $474 · 2024: $193 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,014.71 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $596.73 | 2020-2025 | Acessa Provu System, Coolseal Generator, Thinprep 2000 Processor |
| Abbvie INC. | $298.54 | 2019-2023 | |
| Aspira Women'S Health INC | $223.31 | 2022-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $192.74 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $136.85 | 2020-2025 | |
| Pfizer INC. | $97.97 | 2019-2025 | |
| Astellas Pharma US INC | $88.77 | 2024-2025 | Veozah |
| Myriad Women'S Health, INC. | $86.34 | 2023 | Myrisk |
| Avion Pharmaceuticals | $81.18 | 2019-2021 | |
| Exeltis, USA INC. | $72.95 | 2021-2025 | Slynd |
| Therapeuticsmd, INC. | $53.47 | 2019-2021 | |
| Myovant Sciences INC. | $52.64 | 2021-2022 | |
| Millicent US INC | $49.48 | 2024-2025 | Femlyv |
| Evofem Biosciences, INC. | $48.26 | 2022-2025 | Phexxi, Solosec, Phexx |
| Coopersurgical, INC. | $45.41 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $41.56 | 2021-2023 | |
| Organon LLC | $41.45 | 2025 | Nexplanon |
| Daiichi Sankyo INC. | $40.32 | 2020-2021 | |
| Exact Sciences Corporation | $37.76 | 2023-2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $24.21 | 2025 | Gemtesa |
| Abbott Laboratories | $22.35 | 2021 | |
| Agile Therapeutics, INC. | $20.82 | 2024 | Twirla |
| Ascend Therapeutics US, LLC | $20.31 | 2023 | |
| Mission Pharmacal Company | $19.01 | 2020 | |
| Duchesnay USA Incorporated | $18.87 | 2019 | |
| Medicem INC. | $18.03 | 2020 | |
| Lupin INC. | $16.06 | 2020 | |
| Meditrina | $15.82 | 2023 | |
| Terumo Medical Corporation | $14.90 | 2020 | |
| Allergan, INC. | $13.67 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Fraley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.